Portfolio company
BioLamina
Sweden · £14.4m raised
Raised
£14.4m
Latest stage
Growth
Rounds recorded
1
Backed by
1 investor
Sectors
About
This company produces recombinant human laminin proteins used as cell culture substrates by researchers and regenerative medicine companies to develop stem cell therapies.
SourceFunding history · 1
Similar companies
PL BioScience
This company manufactures human platelet lysate for use by researchers and pharmaceutical organisations in cell culture and regenerative medicine applications.
Scinus Group
This company develops automated, closed bioreactor systems for large-scale cell expansion, serving the cell therapy and regenerative medicine industries.
ReproGo
This regenerative medicine company develops stem cell-derived vascular cells and organoids for drug screening and treating chronic wounds and cardiovascular diseases.
StemSight
This company develops stem cell therapies using biomaterials to treat corneal blindness in patients with limbal stem cell deficiency and other eye conditions.
Sanguine Biosciences
This company provides human biospecimens and patient data to researchers and pharmaceutical companies to support drug discovery and cell therapy development.
Cellink
This company develops 3D bioprinters and bioinks for researchers in academic, pharmaceutical and industrial laboratories to create human tissue models and organs.
The Electrospinning Company
This company manufactures electrospun nanofibre biomaterials and scaffolds for medical device manufacturers and researchers specialising in tissue engineering and regenerative medicine.
Axol Bioscience
This company supplies human induced pluripotent stem cells and reagents to biopharmaceutical and academic organisations for drug discovery and disease modelling.
